F/M Investments’s Akero Therapeutics AKRO Stock Holding History

F/M Investments’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-29,675	Closed	-$1.41M	–	431
2025 Q3	$1.41M	Buy	29,675 +11,691	+65%	+$566K	0.05%	279
2025 Q2	$960K	Sell	17,984 -10,606	-37%	-$482K	0.03%	291
2025 Q1	$1.16M	Sell	28,590 -17,188	-38%	-$729K	0.05%	276
2024 Q4	$1.27M	Buy	+45,778	New	+$1.39M	0.05%	271

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

F/M Investments's AKRO Position: Q4 2025 in Review

F/M Investments sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 29,675 shares — an estimated $1.41M sold.

F/M Investments first reported a position in AKRO in Q4 2024 and held it in 4 quarters. The position peaked at $1.41M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

F/M Investments reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
F/M Investments sold 29,675 Akero Therapeutics shares in Q4 2025, an estimated $1.41M.
F/M Investments first reported a position in Akero Therapeutics in Q4 2024 and held it in 4 quarters.
F/M Investments's Akero Therapeutics position peaked at $1.41M in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on F/M Investments's 13F filing for Q4 2025, filed 3 Feb 2026.